Cagrilintide 5mg (Coming Soon)

Cagrilintide is a long-acting analogue of amylin, a naturally occurring peptide that is released in conjunction with insulin. Cagrilintide has shown promise in animal trials as a treatment for obesity and type 2 diabetes. It has been studied for benefits not just in type 2 diabetes, but for liver damage, alcohol-related liver disease, and heart/blood vessel disease. There is some speculation about the role of this peptide in Alzheimer’s disease as well, but no research has been published in that particular sub-domain.

Disclaimer: “Cagrilintide” is the USAN-designated nonproprietary name for the compound and is not owned or trademarked by any entity. This listing is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Cagrilintide is strictly intended for in vitro laboratory research use and is not approved for human or animal use.

This Product is For Research Use Only.